Research Article

Evaluation of Treatment Results with Direct Acting Antiviral Drugs of Cirrhotic/Non-cirrhotic Chronic Liver Disease Caused by Hepatitis C Virus Genotype 1b Infection
  • Mustafa Doğan
  • Birol Topçu
  • Rıtvan Karaali
  • İlknur Erdem
Viral Hepat J 2020; 26: 43-48 DOI: 10.4274/vhd.galenos.2020.2020.0016
Hepatitis C Virus Genotype Distribution in Forensic Cases
  • Nihan Ziyade
  • Özgür Yanılmaz
  • Neval Elgörmüş
  • Murat Nihat Arslan
Viral Hepat J 2020; 26: 49-55 DOI: 10.4274/vhd.galenos.2020.2019.0016
Genotype Distribution of Hepatitis C Virus in Hatay Province of Turkey
  • Mehmet Çabalak
  • Tayibe Bal
  • Mehmet Demir
  • Sabahattin Ocak
  • Yusuf Önlen
Viral Hepat J 2020; 26: 56-60 DOI: 10.4274/vhd.galenos.2020.2020.0009
Intravenous Drug Use Rates and Results of Direct-acting Antiviral Treatment in Prisoner Patients
  • Mehmet Çabalak
  • Tayibe Bal
Viral Hepat J 2020; 26: 61-64 DOI: 10.4274/vhd.galenos.2020.2020.0015
Correlation between Hepatitis C Virus Antibodies in Saliva and Serum: A Safe Method for Epidemiological Studies
  • Oya Özlem Eren Kutsoylu
  • Ziya Kuruüzüm
  • Ayşe Yüce
Viral Hepat J 2020; 26: 65-68 DOI: 10.4274/vhd.galenos.2020.2020.0007
The Effect of Switch Treatment on Liver Fibrosis and qHBsAg Levels in Patients with Chronic Hepatitis B
  • Esra Yeşilyurt
  • Muhammed Kaya
  • Gökhan Dindar
  • Seyyid Bilal Açıkgöz
  • Fatih Güzelbulut
  • Hayrunnisa Sezikli
  • Göktuğ Şirin
  • Mesut Sezikli
Viral Hepat J 2020; 26: 69-73 DOI: 10.4274/vhd.galenos.2020.2020.0008
Seroprevalence of Hepatitis A in Children Followed-up with the Diagnosis of Chronic Hepatitis B Infection
  • Uğur Deveci
  • Ufuk Acar
Viral Hepat J 2020; 26: 74-77 DOI: 10.4274/vhd.galenos.2020.2020.0018
Diagnostic Performance of Non-invasive Fibrosis Indexes in Hepatitis B Related Fibrosis
  • Süleyman Sayar
  • Roni Atalay
  • Şüheda Çakmak
  • Gülçiçek Ayrancı
  • Kemal Kürbüz
  • Resul Kahraman
  • Zuhal Çalışkan
  • Oğuzhan Öztürk
  • Hakan Demirdağ
  • Gupse Adalı
  • Kamil Özdil
  • Hamdi Levent Doğanay
Viral Hepat J 2020; 26: 78-84 DOI: 10.4274/vhd.galenos.2020.2019.0038
Age Specific Hepatitis B Surface Antigen (HBsAg) and Anti-HBs Seroprevalence among Patients Admitted to a State Hospital
  • Sibel Yıldız Kaya
  • Abdurrahman Kaya
Viral Hepat J 2020; 26: 85-87 DOI: 10.4274/vhd.galenos.2020.2020.0001
An Evaluation of the Efficacy of High-dose Hepatitis B Vaccine in Patients Using Biological Agents
  • Murat Aydın
  • Firdevs Aksoy
  • Zehra Yıldırım
  • İftihar Köksal
Viral Hepat J 2020; 26: 88-93 DOI: 10.4274/vhd.galenos.2020.2019.0039
The Evaluation of a Hundred Eleven Adult Patients with Acute Hepatitis
  • Abdurrahman Kaya
  • Sibel Yıldız Kaya
  • Bilgül Mete
  • İlker İnanç Balkan
  • Neşe Saltoğlu
  • Ömer Fehmi Tabak
Viral Hepat J 2020; 26: 94-97 DOI: 10.4274/vhd.galenos.2020.2019.0041
The Impact of COVID-19 Pandemic on Treatment, Follow-up and Behavioral Characteristics of Chronic Viral Hepatitis Patients
  • Elif M. Sarıcaoğlu
  • Bircan Kayaaslan
  • Rahmet Güner
Viral Hepat J 2020; 26: 98-103 DOI: 10.4274/vhd.galenos.2020.2019.0019
Evaluation of Hepatitis A Seroprevalance and Epidemiologic Data of Patients Applying to A Medical Faculty Hospital
  • Murat Sağlam
  • Cem Çelik
  • Ayşe Hümeyra Taşkın Kafa
  • Mürşit Hasbek
Viral Hepat J 2020; 26: 104-109 DOI: 10.4274/vhd.galenos.2020.2019.0037

About Journal

Forms

Useful Links

Applications